SAN MATEO, Calif.–(BUSINESS WIRE)–The numbers speak for themselves, RapidAI’s deep clinical AI is delivering results where competitors are falling short. New data from the largest head-to-head study to date proves RapidAI’s LVO detection outperforms Viz.ai by a staggering 33%, detecting far more stroke cases and reducing the risk of missed diagnoses. These findings, along with 17 influential studies, will be showcased at the American Heart Association’s International Stroke Conference (ISC) i
More in Trade Show
Trade Show
Japonská asociace výrobců saké a šóčú oznamuje údaje o vývozu saké v roce 2024: Rekordně vysoký vývoz do 80 zemí, meziročně o 6 % vyšší.
TOKIO–(BUSINESS WIRE)–Výsledky vývozu saké v roce 2024 Japonská asociace výrobců saké a šóčú ...
Trade Show
ComEd Announces $100 Million in EV Rebates Now Available to Boost Charging and EV Adoption Across Northern Illinois
CHICAGO–(BUSINESS WIRE)–ComEd today joined a variety of local and industry stakeholders at the ...
Trade Show
NY NOW 2025 Winter Market Successfully Ignites Innovation, Connection & The Future of Retail
NEW YORK–(BUSINESS WIRE)–The NY NOW 2025 Winter Market, held from February 2 – ...